Table 2.
Demographic characteristics of colorectal carcinoma patients.
| Patients, n | 29 |
|---|---|
| Median age (range) | 67 (44–87) |
| Males, n (%) | 20 (69.0) |
| Females, n (%) | 9 (31.0) |
|
| |
| Metastatic pattern, n (%) | |
| Liver | 20 (69.0) |
| Lung | 11 (37.9) |
| Peritoneum | 5 (17.2) |
| Bone | 3 (10.3) |
| Others | 2 (6.9) |
|
| |
| First-line therapy, n (%) | |
| FOLFOX/bevacizumab | 15 (51.7) |
| FOLFOX/anti-EGFR | 10 (34.5) |
| FOLFIRI/bevacizumab | 4 (13.8) |